Navigation Links
BBK Worldwide Leads Sessions at Key September Events
Date:8/28/2014

BOSTON, Aug. 28, 2014 /PRNewswire/ -- Next month, executives from clinical trial marketing firm BBK Worldwide will lead sessions at three key industry events beginning with Patient-Centered Clinical Trials 2014, to be held at the Hyatt Regency Hotel in Boston, September 4-5. Patient recruitment experts Bonnie A. Brescia, Matthew Stumm, and Aaron Fleishman will share insights on the benefits of employing an effective patient engagement strategy, and how a variety of tactics – from media to mobile apps – can be used to drive study participation and overall trial success.

Event and session details are as follows:

Patient-Centered Clinical Trials 2014
September 4-5, 2014, Boston
Panelist: Bonnie A. Brescia, Founding Principal
Session: "The Multi-Stakeholder World of Clinical – Lost in Execution?"
Date/Time: Thursday, September 4, 9:15 a.m. ET

CenterWatch's 2nd Annual Forum on Optimizing Clinical Research Performance
September 15-16, 2014, Boston
Speaker: Bonnie A. Brescia, Founding Principal
Session: "Engaging Patients via Data Sharing"
Date/Time: Monday, September 15, 10:45 – 11:30 a.m. ET

Speaker: Matthew Stumm, Principal, Creative and Media Strategy
Session: "The Art of Innovation in a Regulatory Environment"
Date/Time: Monday, September 15, 11:30 – 12:15 p.m. ET

World Congress Summit on Patient Centricity and Advocacy
September 29-30, Alexandria, VA
Speaker: Aaron Fleishman, Patient Advocacy and Social Strategies
Session: "Making Social Media Part of the Mix – Bringing the Traditional Relationships to the Digital Forum"
Date/Time: Tuesday, September 30, 10:45 a.m. ET

About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment for the clinical trial industry. BBK's latest innovation is the introduction of adaptive recruitment – a new specialty in clinical trial marketing proven to protect global enrollment integrity, specifically within a changing or threatened landscape. BBK is a privately held, women- owned business, headquartered in Needham, Mass. For more information, visit: www.bbkworldwide.com.

Photo - http://photos.prnewswire.com/prnh/20140604/94427


'/>"/>
SOURCE BBK Worldwide
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. 2 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide
2. Telemedicine and M-Health Convergence: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019
3. CAP Technology is Being Applied to Isolation/Containment Applications Worldwide
4. Global Carbonates Report in Detail Analysis 2013: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2013
5. Isolation Sciences Takes Their Patented CAP Isolation Technology Nationally and Worldwide
6. Piqua Compounding Pharmacy Is First Worldwide to Add High-Tech Mixing System to Ensure Accuracy, Efficiency
7. Small Cells and Femtocells Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019 New Market Research Report Available on Researchmoz.us
8. India Shows Commitment to Pharma Excellence at CPhI Worldwide 2013
9. Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells Industry Trend: Worldwide Industry Latest Market Share, Investment Trends, Growth, Size, Strategy
10. Global Solid Oxide Fuel Cell Market 2012 – 2016: Worldwide Industry Latest Market Share, Investment Trends, Growth, Size, Trends, Strategy And Forecast Research Report
11. GIS Market Analysis in US 2012-2016: Worldwide Industry Latest Market Share, Opportunities, Investment Trends, Growth, Size, Trends, Strategy And Forecast Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... -- Champions Oncology, Inc. (NASDAQ: CSBR ), a ... technology solutions and products to personalize the development and ... new cohorts of PDX models to their existing TumorBank. ... product line in hepatocellular cancer, breast cancer, castrate resistant ... cell lung cancer (including EGFR mutation; ALK/ROS1 positive) PDX ...
(Date:2/16/2017)... Feb. 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... on developing aerosolized KL4 surfactant therapies for respiratory ... influenza study showed that aerosolized KL4 surfactant reduced ... well-established preclinical animal model. The Company believes that ... of evidence that supports the role of KL4 ...
(Date:2/16/2017)... , Feb. 16, 2017 Paradigm Diagnostics ... B financing, adding an additional $3M from New Sciences ... Verde Venture Partners and other strategic partners at the ... further accelerating commercial adoption of their flagship Paradigm Cancer ... expanding the Paradigm cancer registry. Dr. ...
(Date:2/15/2017)... ... February 15, 2017 , ... Executive search firm, ... Officer with GenePeeks. Matt is a veteran life sciences and molecular diagnostics ... company focused on identifying inherited disease risk in future generations. In his new ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 2, 2017  EyeLock LLC, a market leader ... white paper " What You Should Know About Biometrics ... ensuring user authenticity is a growing concern. In traditional ... users. However, traditional authentication schemes such as username/password suffer ... Biometric authentication offers an elegant solution to the problem ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... Biopharm Reports has carried out a ... nuclear magnetic resonance spectroscopy (NMR). This involved the ... practices, developments, trends and end-user plans over the ... opportunities. These areas include growth in the use ... innovation requirements, hyphenated NMR techniques, main suppliers of ...
Breaking Biology News(10 mins):